AIBOTICS, INC. (AIBT) stock: key figures, P/E, revenue and dividend
Health Care · United States
AIBOTICS, INC. financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 2,183.00 USD |
| Gross profit | 2,183.00 USD |
| Operating income | -1.84 m USD |
| EBIT | -1.99 m USD |
| Net income | -2.22 m USD |
Full history since 2017, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About AIBOTICS, INC.
Aibotics Inc., together with its subsidiaries, engages in the study of psychedelics for the treatment of mental health issues in the United States. It provides psychedelic-enhanced holistic methodologies for the treatment of palliative care, depression, and anxiety. The company was formerly known as Mycotopia Therapies, Inc. and changed its name to Aibotics Inc. in February 2025. Aibotics Inc. is based in Miami, Florida.
More stocks
- CAPSTONE COMPANIES, INC. (CAPC)
- VACCINEX, INC. (VCNX)
- Toppoint Holdings Inc. (TOPP)
- PRINCETON CAPITAL CORP (PIAC)
- BIOXYTRAN, INC (BIXT)
- CEA Industries Inc. (BNC)
- Q/C TECHNOLOGIES, INC. (QCLS)
- King Resources, Inc. (KRFG)
- Trillion Energy International Inc. (TRLEF)
- reAlpha Tech Corp. (AIRE)
- Yellowstone Group Ltd. (YSGL)
- Bluejay Diagnostics, Inc. (BJDX)
Not investment advice. All data without warranty, price as of 13.11.2026. Details in the risk notice.